SV2010003599A - Polvo nutricional estable - Google Patents

Polvo nutricional estable

Info

Publication number
SV2010003599A
SV2010003599A SV2010003599A SV2010003599A SV2010003599A SV 2010003599 A SV2010003599 A SV 2010003599A SV 2010003599 A SV2010003599 A SV 2010003599A SV 2010003599 A SV2010003599 A SV 2010003599A SV 2010003599 A SV2010003599 A SV 2010003599A
Authority
SV
El Salvador
Prior art keywords
approximately
hydrolyzed
protein
nutritional powder
compositions
Prior art date
Application number
SV2010003599A
Other languages
English (en)
Inventor
Christine L Clinger
Jeffrey M Boff
Gary E Katz
Paul W Johns
Marti Bergana
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40788959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2010003599(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SV2010003599A publication Critical patent/SV2010003599A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICIONES QUE COMPRENDEN CARBOHIDRATOS; LÍPIDOS, QUE COMPRENDEN ENTRE APROXIMADAMENTE 0,25% Y APROXIMADAMENTE 2,5% DE LECITINA EN PESO DE LÍPIDOS TOTALES; ENTRE APROXIMADAMENTE 90% Y APROXIMADAMENTE 99,5% DE PROTEÍNAS INTACTAS EN PESO DE PROTEÍNAS TOTALES; Y ENTRE APROXIMADAMENTE 0,5% Y APROXIMADAMENTE 10% DE AL MENOS UNA PROTEÍNA HIDROLIZADA SELECCIONADA DEL GRUPO QUE CONSISTE DE PROTEÍNA CASEÍNA HIDROLIZADA Y PROTEÍNA DE SUERO HIDROLIZADA; EN DONDE LA PROTEÍNA HIDROLIZADA TIENE UN GRADO DE HIDRÓLISIS DE ENTRE APROXIMADAMENTE 23% Y APROXIMADAMENTE 90%, Y EN DONDE LAS COMPOSICIONES SON POLVOS NUTRICIONALES. LOS POLVOS NUTRICIONALES PROVEEN MEJORAS EN LA ESTABILIDAD OXIDATIVA Y EL RENDIMIENTO SENSORIAL
SV2010003599A 2007-12-20 2010-06-18 Polvo nutricional estable SV2010003599A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1531807P 2007-12-20 2007-12-20

Publications (1)

Publication Number Publication Date
SV2010003599A true SV2010003599A (es) 2011-01-24

Family

ID=40788959

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2010003599A SV2010003599A (es) 2007-12-20 2010-06-18 Polvo nutricional estable

Country Status (25)

Country Link
US (1) US8377496B2 (es)
EP (1) EP2242382B1 (es)
JP (1) JP2011507518A (es)
CN (1) CN101951789B (es)
AR (1) AR070679A1 (es)
AU (1) AU2008343689A1 (es)
BR (1) BRPI0820584A2 (es)
CA (1) CA2708527C (es)
CL (1) CL2008003809A1 (es)
CO (1) CO6280447A2 (es)
CR (1) CR11508A (es)
DO (1) DOP2010000176A (es)
EC (1) ECSP10010262A (es)
GT (1) GT201000173A (es)
IL (1) IL206132A (es)
MX (1) MX2010006887A (es)
MY (1) MY168206A (es)
NZ (1) NZ585619A (es)
PA (1) PA8808701A1 (es)
PE (1) PE20091332A1 (es)
RU (1) RU2481008C2 (es)
SV (1) SV2010003599A (es)
TW (1) TWI418307B (es)
WO (1) WO2009085388A2 (es)
ZA (1) ZA201003912B (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8460726B2 (en) 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
WO2009126932A2 (en) * 2008-04-10 2009-10-15 Provide Nutrition Fortified liquid protein compositions and methods of making same
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
NZ627238A (en) 2009-04-29 2016-02-26 Amarin Pharmaceuticals Ie Ltd Stable pharmaceutical composition comprising ethyl eicosapentaenoate
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MX2011012586A (es) 2009-05-26 2012-03-26 Advanced Bionutrition Corp Composicion de polvo seco estable que comprende microorganismos biologicamente activos y/o materiales bioactivos y metodos de elaboracion.
MY172372A (en) 2009-06-15 2019-11-21 Amarin Pharmaceuticals Ie Ltd Compositions and methods for lowering triglycerides
TW201112967A (en) * 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
WO2011038122A1 (en) 2009-09-23 2011-03-31 Amarin Corporation Plc Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
RU2535869C2 (ru) 2010-01-28 2014-12-20 Эдванст Бионутришн Корпорейшн Сухая стекловидная композиция для стабилизации и защиты биологически активного материала и способ ее получения
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US8840950B2 (en) * 2010-05-26 2014-09-23 Jacqueline M. Hibbert Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
CN103140145B (zh) 2010-08-13 2014-08-20 高级生物营养公司 用于生物材料的干的贮存稳定用组合物
NZ744990A (en) 2010-11-29 2019-10-25 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
CN102599402B (zh) * 2011-01-25 2013-09-04 光明乳业股份有限公司 一种乳清蛋白组合物及其制备方法
ES2689225T3 (es) * 2011-02-07 2018-11-12 Abbott Laboratories Productos nutricionales que comprenden beta-hidroxi-beta-metilbutirato
CN102273520B (zh) * 2011-08-02 2013-08-07 中国科学院新疆理化技术研究所 乳清营养粉及其制备方法
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
CN107518416A (zh) * 2011-10-14 2017-12-29 雅培制药有限公司 无菌液体蛋白补充剂
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2800469B1 (en) 2012-01-06 2021-08-25 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
CA2866889C (en) * 2012-03-23 2021-08-31 Advanced Bionutrition Corporation Stabilizing composition for biological materials
EP2866801A4 (en) 2012-06-29 2016-02-10 Amarin Pharmaceuticals Ie Ltd METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT SUBJECTED TO STATIN TREATMENT
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
WO2016014514A1 (en) * 2014-07-21 2016-01-28 Abbott Laboratories Nutritional powder with polyunsaturated fatty acid and improved organoleptic properties
US20170202260A1 (en) * 2014-07-21 2017-07-20 Abbott Laboratories Nutritional powder with specific antioxidants
GB2550510A (en) * 2015-01-16 2017-11-22 Welldrinks Ltd Beverage with collagen and additional additives
AU2016297986B8 (en) 2015-07-29 2020-06-11 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
ES2964285T3 (es) * 2015-10-15 2024-04-05 Nutricia Nv Fórmula para lactantes con grasa láctea para promover un crecimiento saludable
EP3397078A1 (en) 2015-12-28 2018-11-07 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
SG11201806286VA (en) * 2016-02-05 2018-08-30 Abbott Lab Whey protein based liquid nutritional composition
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
KR102296068B1 (ko) 2018-09-24 2021-09-02 애머린 파마슈티칼스 아일랜드 리미티드 대상체에서 심혈관 사건의 위험도를 감소시키는 방법
CA3131006A1 (en) * 2019-02-21 2020-08-27 Ingenuity Foods, Inc. Compositions comprising choline and omega-3 fatty acid to nutritionally enhance food products
CN113632993A (zh) * 2021-08-24 2021-11-12 黑龙江八一农垦大学 黑豆-乳清双蛋白运动营养粉

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024849A (en) 1990-05-01 1991-06-18 Nestec S.A. Liquid coffee whitener
US5021245A (en) 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
CA2089920C (en) 1992-02-21 1999-06-15 John D. Johnston Synergistic compositions for extending animal feed shelf life
NL9300848A (nl) 1993-05-14 1994-12-01 Friesland Frico Domo Coop Werkwijze voor de bereiding van lang houdbare melkconcentraten en melkpoeders.
US5405637A (en) 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
WO1995018618A2 (en) * 1994-01-10 1995-07-13 Abbott Lab Enteral formula with ribo-nucleotides
US5635199A (en) 1995-10-27 1997-06-03 Nestec Ltd. Support of pediatric patients
SK112399A3 (en) 1997-02-21 2000-12-11 Abbott Lab Methods and compositions for reducing the incidence of necrotizing enterocolitis
EP1034704A1 (en) 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6294206B1 (en) 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
ATE369045T1 (de) * 2001-11-26 2007-08-15 Nestec Sa Lagerstabiles nahrungsmittelprodukt enthaltend molkenprotein, verfahren zu seiner herstellung und verwendung
RU2262867C2 (ru) * 2002-02-14 2005-10-27 Катков Юрий Адольфович Бад к пище для улучшения репродукции человека (варианты)
US7070825B2 (en) 2002-09-10 2006-07-04 Abbott Laboratories Infant formula
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
CA2558537A1 (en) 2004-03-12 2005-09-29 Nellson Northern Operating Inc. Novel protein layering masses, processes for the manufacture thereof, and related products
US20060198899A1 (en) 2005-03-01 2006-09-07 Gardiner Paul T Supplemental dietary composition for supporting muscle growth, recovery and strength
US20060233915A1 (en) 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
US7618669B2 (en) 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
DE102005031468A1 (de) 2005-07-04 2007-01-18 Basf Ag Wässrige Suspensionen schwer wasserlöslicher oder wasserunlöslicher Wirkstoffe und daraus hergestellte Trockenpulver
BRPI0621481A2 (pt) 2006-03-23 2011-12-13 Nestec Sa suplemento nutricional de alta caloria
ATE524073T1 (de) 2006-03-27 2011-09-15 Nestec Sa Molkenprotein micellen
US7875303B2 (en) 2006-03-31 2011-01-25 Kraft Foods Global Brands Llc Protein system and food products including same
US20070281054A1 (en) 2006-05-31 2007-12-06 Abbott Laboratories Organic powder nutritional formula containing select carbohydrate combinations
WO2010047581A1 (en) 2008-10-24 2010-04-29 N.V. Nutricia Liquid high-fat protein composition

Also Published As

Publication number Publication date
IL206132A (en) 2014-04-30
EP2242382A2 (en) 2010-10-27
ZA201003912B (en) 2011-06-29
AU2008343689A1 (en) 2009-07-09
TW200932128A (en) 2009-08-01
EP2242382B1 (en) 2016-11-16
CR11508A (es) 2011-08-12
RU2010129984A (ru) 2012-01-27
PA8808701A1 (es) 2009-07-23
JP2011507518A (ja) 2011-03-10
CA2708527A1 (en) 2009-07-09
CN101951789B (zh) 2014-02-05
ECSP10010262A (es) 2010-07-30
US8377496B2 (en) 2013-02-19
BRPI0820584A2 (pt) 2015-07-14
MX2010006887A (es) 2010-10-15
WO2009085388A2 (en) 2009-07-09
RU2481008C2 (ru) 2013-05-10
CN101951789A (zh) 2011-01-19
GT201000173A (es) 2012-04-03
TWI418307B (zh) 2013-12-11
CA2708527C (en) 2016-06-14
WO2009085388A3 (en) 2010-09-02
PE20091332A1 (es) 2009-09-30
MY168206A (en) 2018-10-15
AR070679A1 (es) 2010-04-28
US20090162518A1 (en) 2009-06-25
DOP2010000176A (es) 2010-10-15
CL2008003809A1 (es) 2009-10-16
CO6280447A2 (es) 2011-05-20
NZ585619A (en) 2012-06-29
IL206132A0 (en) 2010-11-30

Similar Documents

Publication Publication Date Title
SV2010003599A (es) Polvo nutricional estable
GT201000174A (es) Polvo nutricional estable
ECSP12012066A (es) Emulsiones nutricionales que comprenden
ECSP12012045A (es) Emulsiones nutricionales que comprenden beta-hidroxi-beta-metilbutirato (hmb)de calcio y proteína soluble
CO6382079A2 (es) Composiciones insecticidas estables a base de sulfoximina
AR053803A1 (es) Uso de acido pinolenico
EA201001845A1 (ru) Высокоэффективный антиокислитель на основе трегалулозы
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
CL2019003072A1 (es) Composiciones nutricionales y farmacéuticas encapsuladas.
DOP2021000182A (es) Composiciones, preparacion y usos de paramilo
UY27418A1 (es) Formulaciones en combinación de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilización
EA201071309A1 (ru) Твердая фармацевтическая композиция
DE502005008953D1 (de) Liponsäure-konzentrat
CY1121227T1 (el) Διατροφικη συνθεση, συμπληρωμα τροφης που περιλαμβανει την εν λογω διατροφικη συνθεση και kit που περιλαμβανει το εν λογω συμπληρωμα τροφης
PA8815701A1 (es) Composiciones agrícolas
AR090486A1 (es) Golosina de tres capas con estabilidad temporal mejorada
CY1110089T1 (el) 2-αλκοξυ-3,4,5-τριϋδροξυ-αλκυλαμιδο-βενζοθειαζεπινη, η παρασκευη τους, σε ποιες συνθεσεις περιεχονται και η χρηση τους
TH186147S (th) กล่องบุหรี่
AR080808A1 (es) Producto comestible a base de tomate que comprende micronutrientes endogenos biodisponibles por via oral
RU2003114013A (ru) Способ антиокислительной защиты масел животного происхождения
UY28597A1 (es) Formulaciones farmaceuticas que conservan el sabor con caracteristicas farmaceuticas mejoradas
UY28980A1 (es) Plaguicidas
GT201200065A (es) Composición antiperspirante/desodorante
TH5894A3 (th) องค์ประกอบของยางธรรมชาติหรือยางสังเคราะห์ที่ผ่านกระบวนการวัลคาไนเซชันโดยเปอร์ออกไซด์ที่มีกระดองปลาหมึกเป็นสารเสริมแรง
HRPK20050138B3 (en) Yoghurt using jerusalem artichoke additive

Legal Events

Date Code Title Description
FD Lapse